81. Blockade of TGF-β signaling: a potential target for cancer immunotherapy?. (3rd August 2019) Authors: Ungefroren, Hendrik Journal: Expert opinion on therapeutic targets Issue: Volume 23:Number 8(2019:Aug.) Page Start: 679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
82. Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy. (1st November 2014) Authors: Kovar, Heinrich Journal: Expert opinion on therapeutic targets Issue: Volume 18:Number 11(2014:Nov.) Page Start: 1315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
83. Blood–brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery. (August 2015) Authors: Pardridge, William M Journal: Expert opinion on therapeutic targets Issue: Volume 19:Number 8(2015:Aug.) Page Start: 1059 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
84. Bombesin receptor subtype 3 as a potential target for obesity and diabetes. (September 2015) Authors: González, Nieves; Moreno, Paola; Jensen, Robert T Journal: Expert opinion on therapeutic targets Issue: Volume 19:Number 9(2015:Sep.) Page Start: 1153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
85. Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment. (1st September 2016) Authors: Moreno, Paola; Ramos-Álvarez, Irene; Moody, Terry W.; Jensen, Robert T. Journal: Expert opinion on therapeutic targets Issue: Volume 20:Number 9(2016:Sep.) Page Start: 1055 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
86. Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?. (April 2015) Authors: Nijs, Jo; Meeus, Mira; Versijpt, Jan; Moens, Maarten; Bos, Inge; Knaepen, Kristel; Meeusen, Romain Journal: Expert opinion on therapeutic targets Issue: Volume 19:Number 4(2015:Apr.) Page Start: 565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
87. BRCA mutations in pancreatic cancer and progress in their targeting. (3rd July 2021) Authors: Alkassis, Samer; Yazdanpanah, Omid; Philip, Philip Agop Journal: Expert opinion on therapeutic targets Issue: Volume 25:Number 7(2021) Page Start: 547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
88. Breast cancer treatment and sulfotransferase. (June 2015) Authors: Ji, Xi-Wei; Zhou, Tian-Yan; Lu, Yuan; Wei, Min-Ji; Lu, Wei; Cho, William C Journal: Expert opinion on therapeutic targets Issue: Volume 19:Number 6(2015:Jun.) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
89. Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics. (2nd January 2023) Authors: Ma, Zonghui; Bolinger, Andrew A.; Zhou, Jia; Tian, Bing Journal: Expert opinion on therapeutic targets Issue: Volume 27:Number 1(2023) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
90. C9RAN translation: a potential therapeutic target for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia. (September 2013) Authors: Gendron, Tania F; Cosio, Danielle M; Petrucelli, Leonard Journal: Expert opinion on therapeutic targets Issue: Volume 17:Number 9(2013:Sep.) Page Start: 991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗